"Lithuania trusts experts – the European Medicines Agency and the State Medicines Control Agency – who says that there's no evidence the vaccine does damage. We are watching the situation but we have no plans to stop the vaccination process using this vaccine and only one batch of it has been suspended," Auste Suksta, spokeswoman for the health minister, told BNS on Friday.
On Thursday, Denmark said it had suspended vaccination with the AstraZeneca vaccine for two weeks as some patients developed clots after being injected with this vaccine. Nevertheless, the country's officials paid attention to the fact that it was a preventive decision as there's no causal link between the vaccine and blood clots.
Similar decisions were later made by Norway and Iceland.
Meanwhile, Italy said later it was suspending the use of one AstraZeneca vaccine batch, but different from the ones suspended by Austria, Lithuania and several other EU member states.
Lithuania's Health Ministry said on Tuesday it had suspended the use of one AstraZeneca batch following reports from Austrian institutions on its dangerous adverse reactions.
Lithuania is now using the three EMA-approved COVID-19 vaccines made by Pfizer/BioNTech, Moderna and AstraZeneca.